Showing results (201-210 of 307) with videos related to

Sort By:
Pageof 31
Medicine, Health Care, and Philosophy|February 9, 2018
Balancing animal welfare and assisted reproduction: ethics of preclinical animal research for testing new reproductive technologiesVerna Jans, Wybo Dondorp, Ellen Goossens, et al.
Reproductive Biomedicine Online|April 3, 2023
Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?Shari Mackens, Francisca Pais, Panagiotis Drakopoulos, et al.
Fertility and Sterility|June 29, 2010
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trialEvangelos G Papanikolaou, Human Fatemi, Michel Camus, et al.
Fertility and Sterility|February 18, 2004
Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cyclesKostantinos Zikopoulos, Efstratios M Kolibianakis, Michael Camus, et al.
Human Reproduction (Oxford, England)|October 9, 2004
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trialCatherine Staessen, Peter Platteau, Elvire Van Assche, et al.
Reproductive Biomedicine Online|January 18, 2022
Cumulative live birth rate after ovarian stimulation with freeze-all in women with polycystic ovaries: does the polycystic ovary syndrome phenotype have an impact?Shari Mackens, Panagiotis Drakopoulos, Margot Fauve Moeykens, et al.
Reproductive Biomedicine Online|March 19, 2019
Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role?Joaquin Errázuriz, Panagiotis Drakopoulos, David Pening, et al.
Fertility and Sterility|January 18, 2006
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cyclesEvangelos G Papanikolaou, Cristina Pozzobon, Efstratios M Kolibianakis, et al.
Human Reproduction (Oxford, England)|August 2, 2005
Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective studyEvangelos G Papanikolaou, Elke D'haeseleer, Greta Verheyen, et al.
Human Reproduction Open|February 15, 2020
Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndromeFlorence Belva, Mathieu Roelants, Sietske Vermaning, et al.
Pageof 31